Literature DB >> 21418780

Neuropsychological assessment in systemic lupus erythematosus patients: clinical usefulness of first-choice diagnostic tests in detecting cognitive impairment and preliminary diagnosis of neuropsychiatric lupus.

K Nowicka-Sauer1, Z Czuszynska, Z Smolenska, J Siebert.   

Abstract

OBJECTIVES: To evaluate the usefulness of neuropsychological tests in order to distinguish the first-choice methods useful in quick detection of cognitive impairment in SLE and preliminary diagnosis of neuropsychiatric manifestation. Study aimed at assessment of the prevalence and severity of cognitive deficits in SLE patients and comparison between SLE patients with neuropsychiatric manifestations (NP-SLE) and without ones (non-NP-SLE).
METHODS: 93 out of 104 SLE patients, 57 with NP-SLE and 36 with non-NP-SLE underwent comprehensive neuropsychological examination. Tailor-made structured interview for neuropsychological assessment in SLE (SISLE) was used. Patients' emotional state was assessed by clinical interview and HADS.
RESULTS: Cognitive dysfunction was identified in 57% of SLE patients, 48.4% in 1-3 tests, 8.6% (8 patients) in 4 or more tests (severe decline). Among impaired patients 15% had severe decline. In NP-SLE group 63.2% were impaired vs. 47.2% in non-NP-SLE group. All 8 patients with severe decline were NP-SLE. The dysfunction was irrespective of premorbid intellectual level, age, education, disease duration and steroid treatment. In NP-SLE significantly lower scores were observed in 8 tests (10 parameters).
CONCLUSIONS: Cognitive dysfunction is frequent in SLE patients. The majority of patients has mild deficits, but severe decline is also observed. The dysfunction is more frequent and more pronounced in NP-SLE. The study distinguished 8-test-first-choicebattery useful in detecting cognitive impairment in SLE and in case of severe decline - in preliminary differentiating NP-SLE and non-NP-SLE. Structured interview for psychological/neuropsychological examination of SLE patients is a useful and required tool for a standard patients' assessment.

Entities:  

Mesh:

Year:  2011        PMID: 21418780

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

Review 1.  Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus.

Authors:  Meggan Mackay
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

2.  Global Cognitive Impairment in Systemic Lupus Erythematosus Patients: A Structural MRI Study.

Authors:  Nicolle Zimmermann; Diogo Goulart Corrêa; Tadeu Almodovar Kubo; Tania Maria Netto; Denis Batista Pereira; Rochele Paz Fonseca; Emerson Leandro Gasparetto
Journal:  Clin Neuroradiol       Date:  2015-05-13       Impact factor: 3.649

3.  Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus.

Authors:  Meggan Mackay; Chris C Tang; Bruce T Volpe; Cynthia Aranow; Paul J Mattis; Ricki A Korff; Betty Diamond; David Eidelberg
Journal:  Lupus Sci Med       Date:  2015-03-28

4.  Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.

Authors:  Eric H Chang; Bruce T Volpe; Meggan Mackay; Cynthia Aranow; Philip Watson; Czeslawa Kowal; Justin Storbeck; Paul Mattis; RoseAnn Berlin; Huiyi Chen; Simone Mader; Tomás S Huerta; Patricio T Huerta; Betty Diamond
Journal:  EBioMedicine       Date:  2015-05-30       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.